Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06752577
- Status
- Recruiting
Conditions
- Chronic Kidney Diseases
- Kidney Transplant
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Allogeneic, vertebral bone marrow-derived mesenchymal stem cells (MSC) — DRUG1\) intravenous infusion or 2) combined intravenous plus intra-arterial (to kidney) infusion of cells. Total dose: 200x10\^6 MSC (administered over 15 minutes to 2 hours). Repeat dosing allowed at 6 month intervals.
Study Details
The purpose of this protocol is to treat an intermediate-sized population with chronic kidney disease (CKD) including kidney transplant recipients. The protocol uses allogeneic bone marrow-derived mesenchymal stem cells (MSCs). MSC infusion may be delivered 1) intravenous or 2) intravenous plus intra-arterial to both kidneys. Individuals will have subsequent follow up for safety evaluations. Repeat dosing is allowed.
Key Dates
- Start date
- Dec 22, 2024
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2031
Study Design
- Enrollment
- 75 participants (estimated)
Arms
- Arm: MSCIndividuals with chronic kidney disease (including a kidney transplant that is losing function) will receive allogeneic, bone marrow-derived mesenchymal stem cells (MSC). Two administration routes will be used. Repeat dosing is allowed.
Primary Outcome Measure
Adverse events and/or serious adverse events [ Time Frame: 6 months after each MSC infusion ]
Central Contacts
- Donna K Lawson507-255-7975
- Mayo Clinic Regenerative Nephrology Program
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Jacksonville | Florida | 32224 | Regenerative Nephrology Program LaTonya J Hickson, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Jacksonville, FL
By research site
Related Studies
- BLOOM: Biological Legacy of Origin in Mother-Infant DyadsRecruiting · University of Miami · Miami, Florida
- Ferric Citrate and Chronic Kidney Disease in ChildrenPHASE2 · Recruiting · University of California, Los Angeles · Los Angeles, California
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseasePHASE3 · Recruiting · Prokidney · Huntsville, Alabama
- A Study of Renal Microvessel Imaging for Chronic Kidney DiseasePHASE2 · Enrolling By Invitation · Mayo Clinic · Jacksonville, Florida